Powder Systems Ltd's (PSL's) new GFD™ isolator combines the latest innovation to provide a high containment lab scale filtration and drying solution with the same reliability and benefits as PSL high containment production size filter dryers.
Powder Systems Ltd's (PSL's) new GFD isolator combines the latest innovation to provide a high containment lab scale filtration and drying solution with the same reliability and benefits as PSL high containment production size filter dryers.
The GFD works on a vacuum, has a heated jacket for drying and a removable filtration basket for collection of the product. The new high containment system ensures operator protection and safety for the handling of highly potent and valuable products.
The GFD is available in 3 standard sizes to fulfil the needs of any lab, kilo lab or pilot plant requirement including: MINI LAB GFD (0.002m²), LAB GFD (0.01m²) and MAXI LAB GFD (0.05m²). PSL MINI and LAB GFDs are available with high containment isolation systems.
PSL is an international manufacturer of filtration, drying and high containment isolator solutions for pharmaceutical, biopharmaceutical, chemical and laboratory industries.
PSL was established 22 years ago as an original pioneer of high containment systems and can achieve containment to nanograms level. We have business units and distributors across the world to easily assist our global customer base.
Visit PSL at P-MEC Europe stand 40H59 to see the GFD Isolator. www.powdersystems.com
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.